A Study of LY3090106 in Participants With Sjögren's Syndrome (SS)
Status:
Completed
Trial end date:
2018-09-05
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to learn more about the safety and side effects of the
study drug known as LY3090106 in participants with Sjögren's Syndrome (SS). The study will
also evaluate how much of the study drug gets into the blood stream and how long it takes the
body to remove it.